[China Pharmaceuticals: Shanghai's emerging business scale and profits have little impact on the company.] China Pharmaceutical announced that the company holds a 51% stake in Shanghai Xinxing. At present, Shanghai Xinxing has completely stopped production, and Shanghai Xinxing has notified the relevant units to stop. Sell, use, seal, and recall problem batches, and conduct a comprehensive inventory of problem batches. Shanghai's emerging business scale and profits account for a small proportion of the company and have less impact on the company.